We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-3.55%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$16B
AUM Growth
-$1.4B
Cap. Flow
-$442M
Cap. Flow %
-2.77%
Top 10 Hldgs %
29.19%
Holding
720
New
51
Increased
199
Reduced
358
Closed
49

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$121M
2
ONC
BeOne Medicines Ltd
ONC
+$66.8M
3
ISRG icon
Intuitive Surgical
ISRG
+$56.6M
4
WELL icon
Welltower
WELL
+$48.8M
5
CRDO icon
Credo Technology Group
CRDO
+$45.3M

Top Sells

Rank Stock Value
1
ALTR
Altair Engineering Inc
ALTR
+$67M
2
UNH icon
UnitedHealth
UNH
+$44.7M
3
APH icon
Amphenol
APH
+$43.9M
4
BDX icon
Becton Dickinson
BDX
+$36.4M
5
LLY icon
Eli Lilly
LLY
+$36.1M

Sector Composition

Rank Sector Weight
1 Technology 31.51%
2 Healthcare 25.4%
3 Financials 11.6%
4 Consumer Discretionary 7.99%
5 Industrials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TFC icon
126
Truist Financial
TFC
$64.5B
$27.2M 0.17%
661,258
+90,314
+16% +$4.02M
GEV icon
127
GE Vernova
GEV
$246B
$26.7M 0.17%
87,457
-19,990
-19% -$6.97M
HOLX
128
DELISTED
Hologic
HOLX
$26.6M 0.17%
430,141
-514,191
-54% -$34.1M
RARE icon
129
Ultragenyx Pharmaceutical
RARE
$2.49B
$26.4M 0.17%
728,017
+53,760
+8% +$2.24M
CSL icon
130
Carlisle Companies
CSL
$13.3B
$26.3M 0.16%
77,276
+439
+0.6% +$157K
HR icon
131
Healthcare Realty
HR
$7.54B
$26.1M 0.16%
1,543,440
-186,211
-11% -$3.09M
BIIB icon
132
Biogen
BIIB
$30.5B
$25.6M 0.16%
186,780
-15,184
-8% -$2.17M
IQV icon
133
IQVIA
IQV
$40.5B
$25.2M 0.16%
143,036
-4,867
-3% -$944K
VLTO icon
134
Veralto
VLTO
$24.3B
$25.2M 0.16%
258,687
-2,881
-1% -$288K
BSAC icon
135
Banco Santander Chile
BSAC
$16.3B
$25.1M 0.16%
+1,101,600
New +$23.5M
NUVL
136
DELISTED
Nuvalent
NUVL
$25.1M 0.16%
354,129
-13,966
-4% -$1.09M
KKR icon
137
KKR & Co
KKR
$90.9B
$24.8M 0.16%
214,544
-32,716
-13% -$4.5M
ARGX icon
138
argenx
ARGX
$55.2B
$24.4M 0.15%
41,280
-6,930
-14% -$4.37M
UTHR icon
139
United Therapeutics
UTHR
$26.1B
$24.4M 0.15%
79,213
+4,606
+6% +$1.58M
EQIX icon
140
Equinix
EQIX
$100B
$24.1M 0.15%
29,547
-2,034
-6% -$1.83M
RL icon
141
Ralph Lauren
RL
$22.6B
$24.1M 0.15%
79,474
+53,839
+210% +$13.3M
LRN icon
142
Stride
LRN
$4.18B
$23.9M 0.15%
189,143
+128,947
+214% +$16.3M
MRSH
143
Marsh
MRSH
$94.1B
$23.4M 0.15%
96,023
-4,128
-4% -$937K
ELV icon
144
Elevance Health
ELV
$82.5B
$23.4M 0.15%
53,831
-20,660
-28% -$8.29M
FUTU icon
145
Futu Holdings
FUTU
$14.5B
$23.3M 0.15%
227,392
-122,708
-35% -$12.6M
RVMD icon
146
Revolution Medicines
RVMD
$39B
$23.2M 0.15%
655,134
-1,606
-0.2% -$65.2K
FTNT icon
147
Fortinet
FTNT
$111B
$23.1M 0.14%
239,688
+181,434
+311% +$18.4M
CBRE icon
148
CBRE Group
CBRE
$44.2B
$22.5M 0.14%
172,288
-14,648
-8% -$1.99M
CME icon
149
CME Group
CME
$95.4B
$22M 0.14%
83,044
+14,160
+21% +$3.49M
CLH icon
150
Clean Harbors
CLH
$17.5B
$21.7M 0.14%
109,920
-869
-0.8% -$190K
4 5
6
7 8

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2025 Portfolio in Review

As of Q1 2025, Candriam SCA held 720 positions worth $16B, down 8.1% from $17.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Candriam SCA's Q1 2025 filing shows 51 new, 199 increased, 358 reduced and 49 closed positions. Its largest new stake was BeOne Medicines Ltd: 285,893 shares worth $77.8M. The largest sale was Altair Engineering Inc, an estimated $67M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2025 buy was BeOne Medicines Ltd: 285,893 shares worth $77.8M.
  • Candriam SCA added most to Meta Platforms (Facebook) in Q1 2025, an estimated $121M increase.
  • Candriam SCA's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $44.7M.
  • Candriam SCA fully exited Altair Engineering Inc in Q1 2025, selling an estimated $67M.
  • Candriam SCA's ten largest holdings make up 29% of its $16B portfolio in Q1 2025.
  • Candriam SCA opened 51 new positions and closed 49 in Q1 2025.
  • Candriam SCA's portfolio value fell 8.1% quarter-over-quarter to $16B.

Based on Candriam SCA's 13F filing for Q1 2025, filed 14 May 2025.